InsiderFlow

II Robert C. Goeltz

RCUS

II Robert C. Goeltz serves as officer: Chief Financial Officer at Arcus Biosciences, Inc. (RCUS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$1.03M

Net Position

Net Seller

$1.03M

Companies Traded

1

RCUS

Active Period

Dec 2021 – May 2026

9 total trades

Most Recent

Sell RCUS

May 12, 2026 · $199.0K

II Robert C. Goeltz's Insider Trading at Arcus Biosciences, Inc. (RCUS)

Buys

0 · $0.00

Sells

9 · $1.03M

Total Shares Bought

0

Total Shares Sold

45,183

RCUS Price Chart
Loading chart...
DateTypeValue
May 12, 2026 Sell$199.0K
Dec 31, 2025 Sell$153.2K
Dec 16, 2025 Sell$278.7K
Oct 28, 2025 Sell$100.0K
Jan 3, 2025 Sell$53.9K
Jan 4, 2024 Sell$40.1K
Jun 9, 2023 Sell$81.1K
Dec 16, 2022 Sell$75.4K
Dec 20, 2021 Sell$44.4K